CoChat

Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review

Cai, Luyao, Chen, Guanjie, Yang, Haichen, Bai, Yuanhan · 2023 · International Clinical Psychopharmacology

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

The whole picture of psychotropics for bipolar depression (BPD) remains unclear. This review compares the differences in efficacy and safety profiles among common psychotropics for BPD. MEDLINE, EMBASE, and PsycINFO were searched for proper studies. The changes in the depressive rating scale, remission/response rates, nervous system adverse events (NSAEs), gastrointestinal adverse events (GIAEs), metabolic parameters, and prolactin were compared between medication and placebo or among medications with the Cohen’s d or number needed to treat/harm. The search provided 10 psychotropics for comparison. Atypical antipsychotics (AAPs) were superior to lithium and lamotrigine at alleviating acute depressive symptoms. Lithium was more likely to induce dry mouth and nausea. Cariprazine and aripiprazole seemed to be associated with an increased risk of akathisia and upper GIAEs. Lurasidone was associated with an increased risk of developing akathisia and hyperprolactinemia. Olanzapine, olanzapine–fluoxetine combination (OFC), and quetiapine were associated with an increased risk of NSAEs, metabolic risk, dry mouth, and constipation. Cariprazine, lurasidone, OFC, or quetiapine was optimal monotherapy for BPD. Further studies are needed to assess the efficacy and safety of lamotrigine for treating BPD. Adverse events varied widely across different drug types due to variations in psychopharmacological mechanisms, dosages, titration, and ethnicities.

Overview

Integrity signals

Registry

Crossref · 10.1097/yic.0000000000000449

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 70 references

Cited by

See all 11

Metadata

Authors
Cai, L., Chen, G., Yang, H., & Bai, Y.
Affiliations
  • Department of Bipolar Disorder
  • Shenzhen KangNing Hospital (CN)
Corresponding author
  • Cai, Luyao
  • Chen, Guanjie
Venue
International Clinical Psychopharmacology
Published
2023-03-13
Volume
38
Issue
4
Pages
249-260
ISSN
0268-1315 (ISSN-L)
OpenAlex
W4353017596
Cited by
11
References
70
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 4
FWCI
0.50
Type
journal article
Language
en
Open access
closed
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
bipolar depression, mood stabilizers, antipsychotic drugs, lithium, lamotrigine, cariprazine, aripiprazole, lurasidone, olanzapine, olanzapine-fluoxetine combination, quetiapine, akathisia, hyperprolactinemia, metabolic side effects, gastrointestinal adverse effects, xerostomia, treatment efficacy, drug safety
MeSH terms
Lurasidone Hydrochloride, Quetiapine Fumarate, Lamotrigine, Bipolar Disorder, Humans, Lithium, Psychomotor Agitation, Antipsychotic Agents, Antimanic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review. https://app.cochat.ai/papers/10.1097/yic.0000000000000449
The paper
Cai, L., Chen, G., Yang, H., & Bai, Y. (2023). Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000449

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.